HCV status | All-cause deathsa (n = 606) | Liver-related deaths (n = 56) | Non-liver-related deathsa (n = 550) | ||||||
---|---|---|---|---|---|---|---|---|---|
N (%) | HR (95% CI)b | AR (95% CI)c | N (%) | HR (95% CI)b | AR (95% CI)c | N (%) | HR (95% CI)b | AR (95% CI)c | |
Anti-HCV- | 452 (10.9) | 1d | 41 (12.2) | 1d | 437 (10.5) | 1d | |||
Anti-HCV+ | 154 (45.8) | 1.38 (1.12 – 1.70) | 27.5 (10.7 – 41.2) | 3 (3.3) | 5.90 (3.00 – 11.59) | 83.1 (66.7 – 91.4) | 113 (33.6) | 1.08 (0.84 – 1.37) | 7.4 (-19.0 – 27.0) |
HCV RNA- | 31 (34.4) | 1.09 (0.77 – 1.54) | 8.3 (-29.9 – 35.1) | 38 (15.5) | 3.05 (0.84 – 11.08) | 67.2 (-19.0 – 91.0) | 28 (31.1) | 1.02 (0.72 – 1.46) | 2.0 (-38.9 – 31.5) |
HCV RNA+ | 123 (50.0) | 1.51 (1.18 – 1.94) | 33.8 (15.3 – 48.5) | 41 (12.2) | 6.61 (3.29 – 13.27) | 84.9 (69.6 – 92.5) | 85 (34.6) | 1.11 (0.82 – 1.49) | 9.1 (-22.0 – 32.9) |